DOCSLIB.ORG

GO ID Gene Ontology Gene Symbol GO:0030552 3',5'-Camp Binding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
GO ID Gene Ontology Gene Symbol GO:0030552 3',5'-Camp Binding Supplementary Table 2B. The actual genes involved in each gene ontology term among a set of 687 inter- histological subtype-regulated genes. GO_ID Gene ontology Gene Symbol GO:0030552 3',5'-cAMP_binding PRKAR2B GO:0030552 3',5'-cAMP_binding PRKAR2A GO:0003854 3-beta-hydroxy-delta5-steroid_dehydrogenase_activity HSD3B2 GO:0003854 3-beta-hydroxy-delta5-steroid_dehydrogenase_activity HSD3B1 GO:0008124 4-alpha-hydroxytetrahydrobiopterin_dehydratase_activity PCBD GO:0017168 5-oxoprolinase_(ATP-hydrolyzing)_activity OPLAH GO:0008413 8-oxo-7,8-dihydroguanine_triphosphatase_activity NUDT1 GO:0001612 A2B_adenosine_receptor_activity,_G-protein_coupled ADORA2B GO:0019413 acetate_biosynthesis ACAS2L GO:0006083 acetate_metabolism ACAS2L GO:0003987 acetate-CoA_ligase_activity ACAS2L GO:0006085 acetyl-CoA_biosynthesis ACAS2L GO:0006084 acetyl-CoA_metabolism ACAS2L GO:0008375 acetylglucosaminyltransferase_activity MGAT5 GO:0016881 acid-D-amino_acid_ligase_activity PAICS GO:0016881 acid-D-amino_acid_ligase_activity RNF128 GO:0016878 acid-thiol_ligase_activity SUCLA2 GO:0016878 acid-thiol_ligase_activity ACAS2L GO:0001669 acrosome ATP6V1E2 GO:0001675 acrosome_formation TBPL1 GO:0003779 actin_binding CAPZA3 GO:0003779 actin_binding MYH11 GO:0003779 actin_binding ARPC1A GO:0003779 actin_binding PLS3 GO:0003779 actin_binding CAPZB GO:0015629 actin_cytoskeleton MYH11 GO:0015629 actin_cytoskeleton CAPZA3 GO:0015629 actin_cytoskeleton ARPC1A GO:0015629 actin_cytoskeleton TNNT3 GO:0015629 actin_cytoskeleton MYOZ2 GO:0015629 actin_cytoskeleton CCT2 GO:0015629 actin_cytoskeleton CAPZB GO:0030036 actin_cytoskeleton_organization_and_biogenesis CAPZA3 GO:0030036 actin_cytoskeleton_organization_and_biogenesis ARPC1A GO:0030036 actin_cytoskeleton_organization_and_biogenesis PLS3 GO:0030036 actin_cytoskeleton_organization_and_biogenesis CAPZB GO:0030036 actin_cytoskeleton_organization_and_biogenesis ELN GO:0051017 actin_filament_bundle_formation ELN GO:0007015 actin_filament_organization ARPC1A GO:0007015 actin_filament_organization PLS3 GO:0007015 actin_filament_organization ELN GO:0030041 actin_filament_polymerization ELN GO:0030029 actin_filament-based_process CAPZA3 GO:0030029 actin_filament-based_process ARPC1A GO:0030029 actin_filament-based_process PLS3 GO:0030029 actin_filament-based_process CAPZB GO:0030029 actin_filament-based_process ELN GO:0008154 actin_polymerization_and/or_depolymerization ELN GO:0000187 activation_of_MAPK LRRN3 GO:0000187 activation_of_MAPK PRKAA1 GO:0000185 activation_of_MAPKKK MSN GO:0017106 activin_inhibitor_activity INHA GO:0006953 acute-phase_response F2 GO:0006953 acute-phase_response FN1 GO:0006953 acute-phase_response PAP GO:0004254 acylaminoacyl-peptidase_activity APEH GO:0006639 acylglycerol_metabolism GK2 GO:0006639 acylglycerol_metabolism APOB GO:0008415 acyltransferase_activity GGTLA1 1:159 Skotheim et al., Supplementary Table 2B GO_ID Gene ontology Gene Symbol GO:0008415 acyltransferase_activity FEN1 GO:0004000 adenosine_deaminase_activity TENR GO:0001609 adenosine_receptor_activity,_G-protein_coupled ADORA2B GO:0030554 adenyl_nucleotide_binding PRKAA1 GO:0030554 adenyl_nucleotide_binding GK2 GO:0030554 adenyl_nucleotide_binding PRKAR2B GO:0030554 adenyl_nucleotide_binding NARS GO:0030554 adenyl_nucleotide_binding UMPK GO:0030554 adenyl_nucleotide_binding OCA2 GO:0030554 adenyl_nucleotide_binding MAPK4 GO:0030554 adenyl_nucleotide_binding WARS GO:0030554 adenyl_nucleotide_binding ITM2B GO:0030554 adenyl_nucleotide_binding CDK8 GO:0030554 adenyl_nucleotide_binding EPHA3 GO:0030554 adenyl_nucleotide_binding MAP3K5 GO:0030554 adenyl_nucleotide_binding NRBP GO:0030554 adenyl_nucleotide_binding MYH11 GO:0030554 adenyl_nucleotide_binding ATP12A GO:0030554 adenyl_nucleotide_binding SLC2A1 GO:0030554 adenyl_nucleotide_binding CDH16 GO:0030554 adenyl_nucleotide_binding TK1 GO:0030554 adenyl_nucleotide_binding DDX20 GO:0030554 adenyl_nucleotide_binding PRKAR2A GO:0030554 adenyl_nucleotide_binding DDX25 GO:0030554 adenyl_nucleotide_binding TESK2 GO:0030554 adenyl_nucleotide_binding GNE GO:0030554 adenyl_nucleotide_binding HSPA1A GO:0030554 adenyl_nucleotide_binding CCT2 GO:0030554 adenyl_nucleotide_binding DHX35 GO:0030554 adenyl_nucleotide_binding ROR1 GO:0017045 adrenocorticotropin-releasing_hormone_activity CRH GO:0016284 alanine_aminopeptidase_activity ENPEP GO:0016284 alanine_aminopeptidase_activity RNPEP GO:0008784 alanine_racemase_activity PROSC GO:0046165 alcohol_biosynthesis PRKAA1 GO:0046165 alcohol_biosynthesis PGK1 GO:0046164 alcohol_catabolism SUCLA2 GO:0046164 alcohol_catabolism LDHA GO:0046164 alcohol_catabolism PARG GO:0046164 alcohol_catabolism PGK1 GO:0006066 alcohol_metabolism SUCLA2 GO:0006066 alcohol_metabolism PRKAA1 GO:0006066 alcohol_metabolism GK2 GO:0006066 alcohol_metabolism PARG GO:0006066 alcohol_metabolism HDLBP GO:0006066 alcohol_metabolism EKI1 GO:0006066 alcohol_metabolism VLDLR GO:0006066 alcohol_metabolism LDHA GO:0006066 alcohol_metabolism IDI1 GO:0006066 alcohol_metabolism PGK1 GO:0006066 alcohol_metabolism ALDH1A3 GO:0006066 alcohol_metabolism SORL1 GO:0006066 alcohol_metabolism APOB GO:0004030 aldehyde_dehydrogenase_[NAD(P)+]_activity ALDH1A3 GO:0004028 aldehyde_dehydrogenase_activity ALDH1A3 GO:0004035 alkaline_phosphatase_activity ALPI GO:0030144 alpha-1,6-mannosyl-glycoprotein_6-beta-N-acetylglucosaminyltransferase_activity MGAT5 GO:0004557 alpha-galactosidase_activity GLA GO:0015268 alpha-type_channel_activity MID1 GO:0015268 alpha-type_channel_activity FXYD6 GO:0015268 alpha-type_channel_activity GRIN2D 2:159 Skotheim et al., Supplementary Table 2B GO_ID Gene ontology Gene Symbol GO:0015268 alpha-type_channel_activity CLIC6 GO:0015268 alpha-type_channel_activity CACNA1C GO:0015268 alpha-type_channel_activity SCN9A GO:0015837 amine/polyamine_transport SLC7A11 GO:0005275 amine/polyamine_transporter_activity SLC7A11 GO:0009309 amine_biosynthesis TMLHE GO:0009309 amine_biosynthesis BCAT1 GO:0009309 amine_biosynthesis EKI1 GO:0009309 amine_biosynthesis CBS GO:0009310 amine_catabolism INDO GO:0009308 amine_metabolism NARS GO:0009308 amine_metabolism BCAT1 GO:0009308 amine_metabolism PCBD GO:0009308 amine_metabolism CDH16 GO:0009308 amine_metabolism HS2ST1 GO:0009308 amine_metabolism EKI1 GO:0009308 amine_metabolism INDO GO:0009308 amine_metabolism TMLHE GO:0009308 amine_metabolism GNE GO:0009308 amine_metabolism WARS GO:0009308 amine_metabolism TTR GO:0009308 amine_metabolism GFPT2 GO:0009308 amine_metabolism CBS GO:0043038 amino_acid_activation NARS GO:0043038 amino_acid_activation WARS GO:0043038 amino_acid_activation CDH16 GO:0006519 amino_acid_and_derivative_metabolism CKMT2 GO:0006519 amino_acid_and_derivative_metabolism NARS GO:0006519 amino_acid_and_derivative_metabolism BCAT1 GO:0006519 amino_acid_and_derivative_metabolism GLB1 GO:0006519 amino_acid_and_derivative_metabolism PCBD GO:0006519 amino_acid_and_derivative_metabolism CDH16 GO:0006519 amino_acid_and_derivative_metabolism EKI1 GO:0006519 amino_acid_and_derivative_metabolism INDO GO:0006519 amino_acid_and_derivative_metabolism TMLHE GO:0006519 amino_acid_and_derivative_metabolism WARS GO:0006519 amino_acid_and_derivative_metabolism TTR GO:0006519 amino_acid_and_derivative_metabolism CKB GO:0006519 amino_acid_and_derivative_metabolism GFPT2 GO:0006519 amino_acid_and_derivative_metabolism CBS GO:0008652 amino_acid_biosynthesis BCAT1 GO:0008652 amino_acid_biosynthesis CBS GO:0009063 amino_acid_catabolism INDO GO:0042398 amino_acid_derivative_biosynthesis TMLHE GO:0042398 amino_acid_derivative_biosynthesis CKMT2 GO:0042398 amino_acid_derivative_biosynthesis GLB1 GO:0042398 amino_acid_derivative_biosynthesis EKI1 GO:0042219 amino_acid_derivative_catabolism INDO GO:0006575 amino_acid_derivative_metabolism TMLHE GO:0006575 amino_acid_derivative_metabolism CKMT2 GO:0006575 amino_acid_derivative_metabolism GLB1 GO:0006575 amino_acid_derivative_metabolism TTR GO:0006575 amino_acid_derivative_metabolism CKB GO:0006575 amino_acid_derivative_metabolism EKI1 GO:0006575 amino_acid_derivative_metabolism INDO GO:0006520 amino_acid_metabolism NARS GO:0006520 amino_acid_metabolism BCAT1 GO:0006520 amino_acid_metabolism WARS GO:0006520 amino_acid_metabolism PCBD GO:0006520 amino_acid_metabolism CDH16 GO:0006520 amino_acid_metabolism GFPT2 3:159 Skotheim et al., Supplementary Table 2B GO_ID Gene ontology Gene Symbol GO:0006520 amino_acid_metabolism INDO GO:0006520 amino_acid_metabolism CBS GO:0015359 amino_acid_permease_activity SLC7A11 GO:0006865 amino_acid_transport SLC7A11 GO:0015171 amino_acid_transporter_activity SLC7A11 GO:0005279 amino_acid-polyamine_transporter_activity SLC7A11 GO:0006040 amino_sugar_metabolism GNE GO:0006022 aminoglycan_metabolism HS2ST1 GO:0004177 aminopeptidase_activity ENPEP GO:0004177 aminopeptidase_activity RNPEP GO:0030601 aminopeptidase_B_activity RNPEP GO:0016208 AMP_binding PRKAR2B GO:0016208 AMP_binding PRKAR2A GO:0003876 AMP_deaminase_activity AMPD2 GO:0004882 androgen_receptor_activity AR GO:0001525 angiogenesis EPAS1 GO:0001525 angiogenesis ADORA2B GO:0001595 angiotensin_receptor_activity AGTRAP GO:0004945 angiotensin_type_II_receptor_activity AGTRAP GO:0005253 anion_channel_activity CLIC6 GO:0006820 anion_transport SLC17A1 GO:0006820 anion_transport SLCO2A1 GO:0006820 anion_transport CLIC6 GO:0006820 anion_transport PTGER3 GO:0008509 anion_transporter_activity OCA2 GO:0008509 anion_transporter_activity SLC17A1 GO:0008509 anion_transporter_activity SLCO2A1 GO:0009952 anterior/posterior_pattern_formation EMX2 GO:0009952 anterior/posterior_pattern_formation EPHA3 GO:0009718 anthocyanin_biosynthesis
Load more

Recommended publications
  • Recombinant Human FLRT1 Catalog Number: 2794-FL
    Recombinant Human FLRT1 Catalog Number: 2794-FL DESCRIPTION Source Mouse myeloma cell line, NS0­derived human FLRT1 protein Ile21­Pro524, with a C­terminal 6­His tag Accession # Q9NZU1 N­terminal Sequence Ile21 Analysis Predicted Molecular 56.3 kDa Mass SPECIFICATIONS SDS­PAGE 70­80 kDa, reducing conditions Activity Measured by the ability of the immobilized protein to support the adhesion of Neuro­2A mouse neuroblastoma cells. Recombinant Human FLRT1 immobilized at 2.5 μg/mL, 100 μL/well, will meidate > 50% Neuro­2A cell adhesion. Optimal dilutions should be determined by each laboratory for each application. Endotoxin Level <0.10 EU per 1 μg of the protein by the LAL method. Purity >95%, by SDS­PAGE under reducing conditions and visualized by silver stain. Formulation Lyophilized from a 0.2 μm filtered solution in PBS. See Certificate of Analysis for details. PREPARATION AND STORAGE Reconstitution Reconstitute at 200 μg/mL in sterile PBS. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. Stability & Storage Use a manual defrost freezer and avoid repeated freeze­thaw cycles. l 12 months from date of receipt, ­20 to ­70 °C as supplied. l 1 month, 2 to 8 °C under sterile conditions after reconstitution. l 3 months, ­20 to ­70 °C under sterile conditions after reconstitution. BACKGROUND FLRT1 is one of three FLRT (fibronectin, leucine rich repeat, transmembrane) glycoproteins expressed in distinct areas of the developing brain and other tissues (1, 2). The 90 kDa type I transmembrane (TM) human FLRT1 is synthesized as a 646 amino acid (aa) precursor with a 20 aa signal sequence, a 504 aa extracellular domain (ECD), a 21 aa TM segment and a 101 aa cytoplasmic region.
    [Show full text]
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • Regulation of Cdc42 and Its Effectors in Epithelial Morphogenesis Franck Pichaud1,2,*, Rhian F
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs217869. doi:10.1242/jcs.217869 REVIEW SUBJECT COLLECTION: ADHESION Regulation of Cdc42 and its effectors in epithelial morphogenesis Franck Pichaud1,2,*, Rhian F. Walther1 and Francisca Nunes de Almeida1 ABSTRACT An overview of Cdc42 Cdc42 – a member of the small Rho GTPase family – regulates cell Cdc42 was discovered in yeast and belongs to a large family of small – polarity across organisms from yeast to humans. It is an essential (20 30 kDa) GTP-binding proteins (Adams et al., 1990; Johnson regulator of polarized morphogenesis in epithelial cells, through and Pringle, 1990). It is part of the Ras-homologous Rho subfamily coordination of apical membrane morphogenesis, lumen formation and of GTPases, of which there are 20 members in humans, including junction maturation. In parallel, work in yeast and Caenorhabditis elegans the RhoA and Rac GTPases, (Hall, 2012). Rho, Rac and Cdc42 has provided important clues as to how this molecular switch can homologues are found in all eukaryotes, except for plants, which do generate and regulate polarity through localized activation or inhibition, not have a clear homologue for Cdc42. Together, the function of and cytoskeleton regulation. Recent studies have revealed how Rho GTPases influences most, if not all, cellular processes. important and complex these regulations can be during epithelial In the early 1990s, seminal work from Alan Hall and his morphogenesis. This complexity is mirrored by the fact that Cdc42 can collaborators identified Rho, Rac and Cdc42 as main regulators of exert its function through many effector proteins.
    [Show full text]
  • CCT2 Antibody A
    Revision 5 C 0 2 - t CCT2 Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 1 6 Web: [email protected] 5 www.cellsignal.com 3 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP H M R Mk Endogenous 54 Rabbit P78371 10576 Product Usage Information 6. McCormack, E.A. et al. (2001) J Struct Biol 135, 198-204. Application Dilution Western Blotting 1:1000 Immunoprecipitation 1:100 Storage Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity CCT2 Antibody detects endogenous levels of total CCT2 protein. Species Reactivity: Human, Mouse, Rat, Monkey Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to human CCT2. Antibodies are purified by protein A and peptide affinity chromatography. Background CCT2 is one of eight largely unrelated subunit proteins found in a protein chaperone complex known as the chaperonin-containing TCP-1 (CCT) or TRiC complex. The CCT complex is an abundanct cytoslic component that is credited with helping newly synthesized polypeptides adopt the correct conformation (1). Proteins that fold and assemble with the help of CCT include the cytoskeletal proteins actin and tubulin as well as up to 15% of newly synthesized eukaryotic proteins (2). CCT2 is the β-subunit of the chaperone complex and is one of several CCT proteins that exhibit increased expression in response to stress.
    [Show full text]
  • RNA-Seq Alignment to Individualized Genomes Improves Transcript Abundance Estimates in Multiparent Populations
    MULTIPARENTAL POPULATIONS RNA-Seq Alignment to Individualized Genomes Improves Transcript Abundance Estimates in Multiparent Populations Steven C. Munger,* Narayanan Raghupathy,* Kwangbom Choi,* Allen K. Simons,* Daniel M. Gatti,* Douglas A. Hinerfeld,* Karen L. Svenson,* Mark P. Keller,† Alan D. Attie,† Matthew A. Hibbs,*,‡ Joel H. Graber,* Elissa J. Chesler,* and Gary A. Churchill*,1 *The Jackson Laboratory, Bar Harbor, Maine 04609, †University of Wisconsin, Madison, Wisconsin 53705, and ‡Trinity University, San Antonio, Texas 78212 ORCID ID: 0000-0002-8458-1871 (S.C.M.) ABSTRACT Massively parallel RNA sequencing (RNA-seq) has yielded a wealth of new insights into transcriptional regulation. A first step in the analysis of RNA-seq data is the alignment of short sequence reads to a common reference genome or transcriptome. Genetic variants that distinguish individual genomes from the reference sequence can cause reads to be misaligned, resulting in biased estimates of transcript abundance. Fine-tuning of read alignment algorithms does not correct this problem. We have developed Seqnature software to construct individualized diploid genomes and transcriptomes for multiparent populations and have implemented a complete analysis pipeline that incorporates other existing software tools. We demonstrate in simulated and real data sets that alignment to individualized transcriptomes increases read mapping accuracy, improves estimation of transcript abundance, and enables the direct estimation of allele-specific expression. Moreover, when applied to expression QTL mapping we find that our individualized alignment strategy corrects false-positive linkage signals and unmasks hidden associations. We recommend the use of individualized diploid genomes over reference sequence alignment for all applications of high-throughput sequencing technology in genetically diverse populations.
    [Show full text]
  • Stelios Pavlidis3, Matthew Loza3, Fred Baribaud3, Anthony
    Supplementary Data Th2 and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in UBIOPRED Chih-Hsi Scott Kuo1.2, Stelios Pavlidis3, Matthew Loza3, Fred Baribaud3, Anthony Rowe3, Iaonnis Pandis2, Ana Sousa4, Julie Corfield5, Ratko Djukanovic6, Rene 7 7 8 2 1† Lutter , Peter J. Sterk , Charles Auffray , Yike Guo , Ian M. Adcock & Kian Fan 1†* # Chung on behalf of the U-BIOPRED consortium project team 1Airways Disease, National Heart & Lung Institute, Imperial College London, & Biomedical Research Unit, Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; 2Department of Computing & Data Science Institute, Imperial College London, United Kingdom; 3Janssen Research and Development, High Wycombe, Buckinghamshire, United Kingdom; 4Respiratory Therapeutic Unit, GSK, Stockley Park, United Kingdom; 5AstraZeneca R&D Molndal, Sweden and Areteva R&D, Nottingham, United Kingdom; 6Faculty of Medicine, Southampton University, Southampton, United Kingdom; 7Faculty of Medicine, University of Amsterdam, Amsterdam, Netherlands; 8European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, France. †Contributed equally #Consortium project team members are listed under Supplementary 1 Materials *To whom correspondence should be addressed: [email protected] 2 List of the U-BIOPRED Consortium project team members Uruj Hoda & Christos Rossios, Airways Disease, National Heart & Lung Institute, Imperial College London, UK & Biomedical Research Unit, Biomedical Research Unit, Royal
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Investigation of Copy Number Variations on Chromosome 21 Detected by Comparative Genomic Hybridization
    Li et al. Molecular Cytogenetics (2018) 11:42 https://doi.org/10.1186/s13039-018-0391-3 RESEARCH Open Access Investigation of copy number variations on chromosome 21 detected by comparative genomic hybridization (CGH) microarray in patients with congenital anomalies Wenfu Li, Xianfu Wang and Shibo Li* Abstract Background: The clinical features of Down syndrome vary among individuals, with those most common being congenital heart disease, intellectual disability, developmental abnormity and dysmorphic features. Complex combination of Down syndrome phenotype could be produced by partially copy number variations (CNVs) on chromosome 21 as well. By comparing individual with partial CNVs of chromosome 21 with other patients of known CNVs and clinical phenotypes, we hope to provide a better understanding of the genotype-phenotype correlation of chromosome 21. Methods: A total of 2768 pediatric patients sample collected at the Genetics Laboratory at Oklahoma University Health Science Center were screened using CGH Microarray for CNVs on chromosome 21. Results: We report comprehensive clinical and molecular descriptions of six patients with microduplication and seven patients with microdeletion on the long arm of chromosome 21. Patients with microduplication have varied clinical features including developmental delay, microcephaly, facial dysmorphic features, pulmonary stenosis, autism, preauricular skin tag, eye pterygium, speech delay and pain insensitivity. We found that patients with microdeletion presented with developmental delay, microcephaly, intrauterine fetal demise, epilepsia partialis continua, congenital coronary anomaly and seizures. Conclusion: Three patients from our study combine with four patients in public database suggests an association between 21q21.1 microduplication of CXADR gene and patients with developmental delay. One patient with 21q22.13 microdeletion of DYRK1A shows association with microcephaly and scoliosis.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Differentially Expressed on Collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All Rights Reserved. Symbol Entrez
    Differentially expressed on collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All rights reserved. Symbol Entrez Gene Name Affymetrix Fold Change Location Family ALDH1A3 aldehyde dehydrogenase 1 family, member A3 203180_at -5.43125168 Cytoplasm enzyme 209772_s_ Plasma CD24 CD24 molecule at -4.32890229 Membrane other HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 204130_at -4.1099197 Cytoplasm enzyme Plasma AMOTL2 angiomotin like 2 203002_at -2.82872773 Membrane other transcription DLX2 distal-less homeobox 2 207147_at -2.74996362 Nucleus regulator 221215_s_ RIPK4 receptor-interacting serine-threonine kinase 4 at -2.56556472 Nucleus kinase PLK2 polo-like kinase 2 (Drosophila) 201939_at -2.47054478 Nucleus kinase ALDH3A1 aldehyde dehydrogenase 3 family, memberA1 205623_at -2.30532989 Cytoplasm enzyme TXNRD1 thioredoxin reductase 1 201266_at -2.27936909 Cytoplasm enzyme Extracellular CYR61 cysteine-rich, angiogenic inducer, 61 201289_at -2.09052668 Space other 214212_x_ FERMT2 fermitin family homolog 2 (Drosophila) at -1.87478183 Cytoplasm other Plasma RIT1 Ras-like without CAAX 1 209882_at -1.77586775 Membrane enzyme 210297_s_ Extracellular MSMB microseminoprotein, beta- at -1.72177723 Space other Extracellular PI3 peptidase inhibitor 3, skin-derived 203691_at -1.68135697 Space other ALDH3B1 aldehyde dehydrogenase 3 family, member B1 205640_at -1.67376791 Cytoplasm enzyme 202124_s_ Plasma TRAK2 trafficking protein, kinesin binding 2 at -1.6367793 Membrane transporter BMP and activin membrane-bound inhibitor Plasma BAMBI
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Genetic and Pharmacological Approaches to Preventing Neurodegeneration
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2012 Genetic and Pharmacological Approaches to Preventing Neurodegeneration Marco Boccitto University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Neuroscience and Neurobiology Commons Recommended Citation Boccitto, Marco, "Genetic and Pharmacological Approaches to Preventing Neurodegeneration" (2012). Publicly Accessible Penn Dissertations. 494. https://repository.upenn.edu/edissertations/494 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/494 For more information, please contact [email protected]. Genetic and Pharmacological Approaches to Preventing Neurodegeneration Abstract The Insulin/Insulin-like Growth Factor 1 Signaling (IIS) pathway was first identified as a major modifier of aging in C.elegans. It has since become clear that the ability of this pathway to modify aging is phylogenetically conserved. Aging is a major risk factor for a variety of neurodegenerative diseases including the motor neuron disease, Amyotrophic Lateral Sclerosis (ALS). This raises the possibility that the IIS pathway might have therapeutic potential to modify the disease progression of ALS. In a C. elegans model of ALS we found that decreased IIS had a beneficial effect on ALS pathology in this model. This beneficial effect was dependent on activation of the transcription factor daf-16. To further validate IIS as a potential therapeutic target for treatment of ALS, manipulations of IIS in mammalian cells were investigated for neuroprotective activity. Genetic manipulations that increase the activity of the mammalian ortholog of daf-16, FOXO3, were found to be neuroprotective in a series of in vitro models of ALS toxicity.
    [Show full text]